[1]
|
Król M,Kepinska M. Human nitric oxide synthase-its functions,polymorphisms,and inhibitors in the context of inflammation[J]. Int J Mol Sci,2020,22(1):56. doi: 10.3390/ijms22010056
|
[2]
|
Singh N,Baby D,Rajguru J P,et al. Inflammation and cancer[J]. Ann Afr Med,2019,18(3):121-126. doi: 10.4103/aam.aam_56_18
|
[3]
|
Suarez Carmona M,Lesage J,Cataldo D,et al. EMT and inflammation:Inseparable actors of cancer progression[J]. Mol Oncol,2017,11(7):805-823. doi: 10.1002/1878-0261.12095
|
[4]
|
Khan F H,Dervan E,Bhattacharyya D D,et al. The role of nitric oxide in cancer:Master regulator or not?[J]. Int J Mol Sci,2020,21(24):9393. doi: 10.3390/ijms21249393
|
[5]
|
Hu Y, Xiang J, Su L, et al. The regulation of nitric oxide in tumor progression and therapy [J]. Int J Appl Basic Med Res, 2020, 48(2): 300060520905985.
|
[6]
|
Mnatsakanyan R,Markoutsa S,Walbrunn K,et al. Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique[J]. Nat Commun,2019,10(1):2195. doi: 10.1038/s41467-019-10182-4
|
[7]
|
Chang H C,Guarente L. SIRT1 and other sirtuins in metabolism[J]. Trends Endocrinol Metab,2014,25(3):138-145. doi: 10.1016/j.tem.2013.12.001
|
[8]
|
Kane A E,Sinclair D A. Sirtuins and NAD(+) in the development and treatment of metabolic and cardiovascular diseases[J]. Circ Res,2018,123(7):868-885. doi: 10.1161/CIRCRESAHA.118.312498
|
[9]
|
Ong A L C,Ramasamy T S. Role of Sirtuin1-p53 regulatory axis in aging,cancer and cellular reprogramming[J]. Ageing Res Rev,2018,43(5):64-80.
|
[10]
|
Rezk N A,Lashin M B,Sabbah N A. MiRNA 34-a regulate SIRT-1 and Foxo-1 expression in endometriosis[J]. Non-coding RNA research,2021,6(1):35-41. doi: 10.1016/j.ncrna.2021.02.002
|
[11]
|
Rifaï K,Judes G,Idrissou M,et al. SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer[J]. Oncotarget,2018,9(55):30661-30678. doi: 10.18632/oncotarget.25771
|
[12]
|
Wang C,Yang W,Dong F,et al. The prognostic role of Sirt1 expression in solid malignancies:A meta-analysis[J]. Oncotarget,2017,8(39):66343-66351. doi: 10.18632/oncotarget.18494
|
[13]
|
Goto T,Haruma K,Kitadai Y,et al. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients[J]. Clin Cancer Res,1999,5(6):1411-1415.
|
[14]
|
Kornberg M D,Sen N,Hara M R,et al. GAPDH mediates nitrosylation of nuclear proteins[J]. Nat Cell Biol,2010,12(11):1094-1100. doi: 10.1038/ncb2114
|
[15]
|
Zhou D,Yang F,Lin L,et al. The sirtuin 1 activator SRT1720 alleviated endotoxin-induced fulminant hepatitis in mice[J]. Exp Anim,2021,70(3):302-310. doi: 10.1538/expanim.20-0014
|
[16]
|
Kiernan R,Brès V,Ng R W,et al. Post-activation turn-off of nf-kappa B-dependent transcription is regulated by acetylation of p65[J]. J Biol Chem,2003,278(4):2758-2766. doi: 10.1074/jbc.M209572200
|
[17]
|
Shinozaki S,Chang K,Sakai M,et al. Inflammatory stimuli induce inhibitory s-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65[J]. Sci Signal,2014,7(351):ra106.
|
[18]
|
Gregorio D E,Colell A,Morales A,et al. Relevance of SIRT1-nf-κB axis as therapeutic target to ameliorate inflammation in liver disease[J]. Int J Mol Sci,2020,21(11):3858. doi: 10.3390/ijms21113858
|
[19]
|
Nopparat C,Sinjanakhom P,Govitrapong P. Melatonin reverses H2O2 -induced senescence in SH-SY5Y cells by enhancing autophagy via sirtuin 1 deacetylation of the RelA/p65 subunit of nf-κB[J]. J Pineal Res,2017,63(1):e12407. doi: 10.1111/jpi.12407
|
[20]
|
Chen Y J,Ching W C,Chen J S,et al. Decoding the s-nitrosoproteomic atlas in individualized human colorectal cancer tissues using a label-free quantitation strategy[J]. J Proteome Res,2014,13(11):4942-4958. doi: 10.1021/pr5002675
|
[21]
|
Guslandi M. Nitric oxide in ulcerative colitis[J]. Lancet,1993,341(8849):905-906.
|
[22]
|
Miller M J,Sandoval M. Nitric oxide. III. A molecular prelude to intestinal inflammation[J]. Am J Physiol,1999,276(4):G795-G799.
|
[23]
|
Zhao Q,Zheng K,Ma C,et al. PTPS facilitates compartmentalized LTBP1 s-nitrosylation and promotes tumor growth under hypoxia[J]. Mol Cell,2020,77(1):95-107. doi: 10.1016/j.molcel.2019.09.018
|
[24]
|
Gao Y,Zhou S,Xu Y,et al. Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer[J]. Nitric oxide,2019,83(2):33-39.
|
[25]
|
Li K,Huang M,Xu P,et al. Microcystins-LR induced apoptosis via s-nitrosylation of GAPDH in colorectal cancer cells[J]. Ecotoxicol Environ Saf,2020,190(3):110096.
|
[26]
|
Leon-Bollotte L,Subramaniam S,Cauvard O,et al. S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells[J]. Gastroenterology,2011,140(7):2009-2018. doi: 10.1053/j.gastro.2011.02.053
|
[27]
|
Zhao J,O'neil M,Schonfeld M,et al. Hepatocellular protein arginine methyltransferase 1 suppresses alcohol-induced hepatocellular carcinoma formation by inhibition of inducible nitric oxide synthase[J]. Hepatol Commun,2020,4(6):790-808. doi: 10.1002/hep4.1488
|
[28]
|
López-Sánchez L M,Corrales F J,López-Pedrera C,et al. Pharmacological impairment of s-nitrosoglutathione or thioredoxin reductases augments protein s-nitrosation in human hepatocarcinoma cells[J]. Anticancer Res,2010,30(2):415-421.
|
[29]
|
Stomberski C T,Hess D T,Stamler J S. Protein s-nitrosylation:Determinants of specificity and enzymatic regulation of s-nitrosothiol-based signaling[J]. Antioxid Redox Signal,2019,30(10):1331-1351. doi: 10.1089/ars.2017.7403
|
[30]
|
Fukumura D,Kashiwagi S,Jain R K. The role of nitric oxide in tumour progression[J]. Nat Rev Cancer,2006,6(7):521-534. doi: 10.1038/nrc1910
|
[31]
|
Luanpitpong S,Chanvorachote P. Nitric oxide and aggressive behavior of lung cancer cells[J]. Anticancer Res,2015,35(9):4585-4592.
|
[32]
|
Wei W,Li B,Hanes M A,et al. S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis[J]. Sci Transl Med,2010,2(19):19ra3.
|
[33]
|
Tang C H,Wei W,Hanes M A,et al. Hepatocarcinogenesis driven by GSNOR deficiency is prevented by iNOS inhibition[J]. Cancer Res,2013,73(9):2897-2904. doi: 10.1158/0008-5472.CAN-12-3980
|
[34]
|
González R,Rodríguez-Hernández M A,Negrete M,et al. Downregulation of thioredoxin-1-dependent CD95 s-nitrosation by sorafenib reduces liver cancer[J]. Redox Biol,2020,34(7):101528.
|
[35]
|
Wei W,Yang Z,Tang C H,et al. Targeted deletion of GSNOR in hepatocytes of mice causes nitrosative inactivation of O6-alkylguanine-DNA alkyltransferase and increased sensitivity to genotoxic diethylnitrosamine[J]. Carcinogenesis,2011,32(7):973-977. doi: 10.1093/carcin/bgr041
|
[36]
|
Kota J,Hancock J,Kwon J,et al. Pancreatic cancer:Stroma and its current and emerging targeted therapies[J]. Cancer Lett,2017,391(4):38-49.
|
[37]
|
Tan C,Li Y,Huang X,et al. Extensive protein s-nitrosylation associated with human pancreatic ductal adenocarcinoma pathogenesis[J]. Cell Death Dis,2019,10(12):914. doi: 10.1038/s41419-019-2144-6
|